Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.47%) to 10559.58, DAX +0.09% to 24066.70, CAC40 (0.64%) to 8274.57, STOXX 600 (0.43%) to 617.27

Apr 15 ,2026

  • Synopsis:

    • European equity markets closed lower and near session lows with Germany bucking the negative trend. Follows broad gains in prior session. Media, financial services and real estate were the best performing sectors. Personal and household goods, construction and telecom underperformed.

    • Markets cautious after decent gains Tuesday amid renewed optimism on Iran. Diplomatic process appears to have gained more traction with Trump saying second round of talks could occur next couple of days. Trump and Vance maintained upbeat tone in talking up prospects of an agreement. However, there remains mixed comments on nuclear issue, the main sticking point in last weekend meeting. Press reports that US and Iran agree in principle to extend two-week ceasefire to allow time for diplomacy. Backchannel talks suggest gaps narrowing. US naval blockade in force though no ships from Iranian ports have attempted to challenge enforcement. Iran's top joined military command has threatened to prevent trade flows in Red Sea if blockade continues.

    • Focus remains on economic impact of Iran conflict. IMF trimmed economic growth forecasts for Eurozone and the UK and revised up inflation outlook on Tuesday. ECB President Lagarde said in a Bloomberg interview that higher energy costs have pushed the Eurozone away from the ECB's base-case outlook, but not yet enough to warrant leaning towards rate increase. IMF recommended central banks wait for evidence of second round effects before tightening policy.

    • On macro data front, French final CPI in line with flash at 1.7% y/y. Eurozone industrial production slightly firmer than forecast. In other news, Trump threatened to change the UK trade deal over PM Starmer's lack of support for Iran war. EU proceeding with plans to double tariffs and halve quotas on steel imports to primarily curb Chinese overcapacity.

    • In earnings news, ASML Holding (ASML.NA) reported Q1 earnings slightly ahead of expectations and raised its FY26 revenue guidance. In France, following yesterday's disappointing sales report from Kering (KER.FP), luxury heavyweight Hermes (RMS.FP) released Q1 revenue numbers below consensus, reinforcing concerns about the sector. Out in the DACHs region, AIXTRON (AIXA.GR) increased its guidance for 2026, whilst Fraport (FRA.GR) and Flughafen Zürich (FHZN.SW) reported March traffic. In the UK, Barratt Redrow (BTRW.LN) and Antofagasta (ANTO.LN) are amongst others in the region to update investors with their latest numbers. Elsewhere, Stellantis (STLAM.IM) issued Q1 consolidated shipment estimates.

    • In M&A, Standard Life (SDLF.LN) confirmed the acquisition of Aegon UK (AGN.NA) for £2.0B in cash and shares, with the transaction expected to complete around the end of 2026. In Italy, according to Repubblica, UniCredit (UCG.IM) is ready to drop its appeal against the TAR ruling that blocked its takeover bid for Banco BPM (BAMI.IM).

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Media +1.62%, Financial Svcs +0.98%, Real Estate +0.61%, Insurance +0.47%, Banks (0.07%), Retail (0.11%), Travel & Leisure (0.19%), Chemicals (0.21%), Autos & Parts (0.25%), Ind Goods & Svcs (0.30%), Technology (0.31%)

      • Underperformers:

        • Persnl & HHold Goods (1.37%), Construct & Mtls (1.03%), Telecom (0.87%), Oil & Gas (0.82%), Food & Beverage (0.82%), Basic Resources (0.68%), Utilities (0.57%), Health Care (0.51%)

    • Macro:

      • Geopolitics:

        • US President Trump has threatened to change the UK trade deal over PM Starmer's lack of support in the Iran war (Telegraph, London Times)

        • Europe advances "European NATO" contingency plan to defend itself if US withdraws support (link)

        • Trump calls Italian PM Meloni "unacceptable" after her criticism of his attack on Pope Leo XIV (Politico)

      • Central Banks:

        • ECB's Lagarde says Eurozone is between baseline and adverse scenarios from Iran war but sees no policy bias yet (Bloomberg)

        • BoE governor Bailey warns new Anthropic AI model could dramatically increase cyber risks (Reuters)

        • BoE's Greene says second-round effects from energy prices will determine need for rate hike (link)

      • Trade/Tariffs:

        • EU agrees to double tariffs and halve steel import quotas from July, hitting UK exports post-Brexit (Guardian)

      • UK:

        • Chancellor Reeves proposes limited defence spending increase of less than £10B despite armed forces funding gap (London Times)

        • Reeves to meet US treasury secretary Bessent amid sharp differences over Iran war economic costs (PAMedia)

    • Company news:

      • Notable Gainers

        • +20.3% AIXA.GR (Aixtron €42.35, +7.16) -- raises FY 2026 guidance

        • +17.9% RNK.LN (Rank Group £1.07, +0.16) -- Q3 trading update

        • +10.3% HYQ.GR (Hypoport €89.65, +8.35) -- Q1 trading update

        • +9.1% BFIT.NA (Basic-Fit €34.12, +2.84) -- KBC upgrade

        • +7.6% RWA.LN (Robert Walters £0.91, +0.06) -- Q1 trading update

        • +7.6% ENRO.SS (Eniro Group SEK0.75, +0.05) -- AI strategic partnership with Sana

        • +7.0% ASAI.LN (ASA International Group £2.29, +0.15) -- FY earnings

        • +6.2% COPN.SW (Cosmo Pharmaceuticals CHF101.40, +5.90) -- Phase III study results for Clascoterone 5%

        • +6.2% SHA0.GR (Schaeffler €8.24, +0.48) -- Q1 pre-close call

        • +6.0% SAGA.LN (Saga Plc £6.17, +0.35) -- FY earnings

        • +5.8% AUS.GR (AT & S Austria Technologie & Systemtechnik €72.50, +4.00)

        • +5.6% DUST.SS (Dustin Group SEK1.54, +0.08) -- Q2 earnings

        • +5.5% ISOFOL.SS (Isofol Medical SEK0.71, +0.04) -- German approval for optimized design of ongoing Phase Ib/II arfolitixorin study

        • +5.0% OCDO.LN (Ocado Group £1.91, +0.09)

        • +4.9% DOM.SS (Dometic Group SEK30.12, +1.40) -- Nordea upgrade

        • +4.7% BOOZT.SS (Boozt Fashion SEK107.10, +4.80)

        • +4.3% GSC1.GR (GESCO SE €14.70, +0.60) -- final FY earnings and 2026 outlook

        • +4.2% HT5.SW (HOCN Ltd. CHF3.75, +0.15) -- places 15.4M shares at offer price of CHF 2.04/sh

        • +2.9% EVT.GR (Evotec €5.55, +0.16) -- new COO

        • +2.3% BOWL.LN (Hollywood Bowl Group £2.71, +0.06) -- H1 trading update

        • +2.3% NOVO.B.DC (Novo Nordisk DKK251.85, +5.70)

        • +1.8% ADJ.GR (ADLER Group €0.17, -0.00)

        • +1.8% STLAM.IM (Stellantis €7.05, +0.12) -- Q1 shipments

      • Notable Decliners

        • -9.3% KER.FP (Kering €254.00, -26.00) -- Q1 revenue

        • -8.2% RMS.FP (Hermes €1,636.50, -146.50) -- Q1 revenue

        • -6.7% ST5.GR (STEICO €20.80, -1.50) -- prelim. Q1 earnings

        • -6.5% STR.AV (STRABAG SE €88.10, -6.10) -- holder offers ~2.36M shares; prices at €86.70/Share -- Bloomberg, citing terms

        • -5.5% HTG.LN (Hunting £4.80, -0.28) -- Q1 trading update

        • -4.9% FXPO.LN (Ferrexpo £0.43, -0.02) -- Q1 production

        • -4.7% ORES.SS (Investment AB Öresund SEK147.40, -7.20) -- Q1 earnings

        • -3.5% IMB.LN (Imperial Brands £28.30, -1.04) -- UBS downgrade

        • -2.9% HVO.LN (hVIVO plc £0.08, -0.00) -- FY earnings

        • -2.8% ALVDM.FP (Voyageurs du Monde €137.00, -4.00) -- FY earnings

        • -1.8% OSE.FP (OSE Immunotherapeutics €3.18, -0.06) -- new deputy CEO and CSO

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: TomTom (TOM2.NA)

        • DACHs: Barry Callebaut (BARN.SW), Gerresheimer (GXI.GR), Voltabox (VOTR.GR), R. Stahl (RSL2.GR), NFON (NFN.GR)

        • France: Pluxee (PLX.FP), Icade (ICAD.FP), Marie Brizard Wine & Spirits (MBWS.FP)

        • Nordics: Kinnevik (KINV.B.SS)

        • Southern Europe: OVS (OVS.IM)

        • UK: Tesco (TSCO.LN), The Beauty Tech Group (TBTG.LN)

      • Trading Update:

        • Benelux: Basic-Fit (BFIT.NA), Sligro Food Group (SLIGR.NA), Fastned (FAST.NA), Econocom Group (ECONB.BB), CM.com (CMCOM.NA)

        • DACHs: VAT Group (VACN.SW), Bystronic (BYS.SW), DocMorris (DOCM.SW), Gurit Holding (GURN.SW)

        • France: Pernod Ricard (RI.FP), Virbac (VIRP.FP), Lagardere (MMB.FP), Maurel et Prom (MAU.FP), Icade (ICAD.FP), Ipsos (IPS.FP), Planisware (PLNW.FP), Thermador Groupe (THEP.FP), PulluP Entertainment (ALPUL.FP), ATEME (ATEME.FP)

        • Nordics: BW Energy (BWE.NO), Bang & Olufsen (BO.DC)

        • UK: Rentokil Initial (RTO.LN), Entain (ENT.LN), Mitie Group (MTO.LN), Dunelm Group (DNLM.LN), Ashmore Group (ASHM.LN), Ninety One (N91.LN), Hays (HAS.LN)

      • Traffic: Aeroport de Paris (ADP.FP), Flughafen Wien (FLU.AV), VINCI (DG.FP)

      • CMD/Events: Medacta Group (MOVE.SW) production site visit, Kering (KER.FP), FUCHS (FPE.GR)

  • Data:

    • Economics:

      • Eurozone Feb Industrial Production (0.6%) y/y vs consensus (1.0%) and prior revised (0.6%) from (1.2%); +0.4% m/m vs consensus +0.3% and prior revised (0.8%) from (1.5%)

      • France Mar CPI +1.7% y/y vs prelim +1.7%; +1.0% m/m vs prelim +0.9%

        • EU Harmonised: +2.0% y/y vs prelim +1.9%; +1.1% m/m vs prelim +1.1%

      • Norway Mar Trade Balance NOK97.5B vs consensus NOK58.8B and prior NOK44.8B

    • Markets:

      • WTI Crude (May 26): +$1.42 or +1.56% to $92.70

      • €-$ +0.0006 or +0.05% to 1.1802

      • £-$ +0.0007 or +0.05% to 1.3573

      • €-£ (0.0001) to 0.8695

      • S&P 500 +0.44%

      • Performance year-to-date

        • FTSE 100: +6.33%

        • DAX: (1.73%)

        • CAC: +1.53%

        • MIB: +7.14%

        • Stoxx 600: +4.24%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.